NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma.

iScience · 2023 · PMC10130926 · PMID 37123230

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp = 1.4e-14actually significant

Comparative analysis of the paired samples revealed highly significant overexpression of NDC80 mRNA in ccRCC samples from TCGA (p = 1.4e-14) and ICGC (p = 1.2e-11) ( Figures 2 B and 2C).

also in 11,749 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.